Abstract
Much of the current effort in HIV-1 vaccine design is directed at achieving T-cell immunity that will result in enough immunological memory to contain HIV-1 infection after acquisition. However, antigenic diversity, plus a lack of understanding of HIV-1 vaccine immunology, have hindered the development of a globally effective cytotoxic Tlymphocyte (CTL)-based vaccine. Cellular response, in using a finite immune system to recognize an infinite number of potential pathogens, exhibits a series of parsimonious features. These features are considered critical in modulating HIV-1 vaccine multiple specificities. We took the features into consideration when the potential epitope coverage (Ec) to circulating strains by current vaccine strategies was analyzed. Based on these analyses, several approaches are proposed to enhance the breadth of vaccine responses and, hence, the potential protective efficacy.
Keywords: HIV-1, CTL, vaccine design, antigen diversity
Current HIV Research
Title: HIV-1 CTL-Based Vaccine Immunogen Selection: Antigen Diversity and Cellular Response Features
Volume: 5 Issue: 1
Author(s): Fusheng Li, Helen Horton, Peter B. Gilbert, Juliana M. McElrath, Lawrence Corey and Steve G. Self
Affiliation:
Keywords: HIV-1, CTL, vaccine design, antigen diversity
Abstract: Much of the current effort in HIV-1 vaccine design is directed at achieving T-cell immunity that will result in enough immunological memory to contain HIV-1 infection after acquisition. However, antigenic diversity, plus a lack of understanding of HIV-1 vaccine immunology, have hindered the development of a globally effective cytotoxic Tlymphocyte (CTL)-based vaccine. Cellular response, in using a finite immune system to recognize an infinite number of potential pathogens, exhibits a series of parsimonious features. These features are considered critical in modulating HIV-1 vaccine multiple specificities. We took the features into consideration when the potential epitope coverage (Ec) to circulating strains by current vaccine strategies was analyzed. Based on these analyses, several approaches are proposed to enhance the breadth of vaccine responses and, hence, the potential protective efficacy.
Export Options
About this article
Cite this article as:
Li Fusheng, Horton Helen, Gilbert B. Peter, McElrath M. Juliana, Corey Lawrence and Self G. Steve, HIV-1 CTL-Based Vaccine Immunogen Selection: Antigen Diversity and Cellular Response Features, Current HIV Research 2007; 5 (1) . https://dx.doi.org/10.2174/157016207779316260
DOI https://dx.doi.org/10.2174/157016207779316260 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |
Call for Papers in Thematic Issues
Management of HIV: Management of HIV: old challenges and new needs
The aim of this thematic issue is to provide the most recent updates regarding the effective management of HIV infection. Antiretroviral therapy (ART) has significantly decreased HIV-related mortality, leading to an enhancement in the quality of life and life expectancy for people living with HIV (PLWH). Despite the numerous advancements ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Small Yet Mighty – MicroRNAs in Plant-Microbe Interactions
MicroRNA Cellular FLICE-Like Inhibitory Protein (C-FLIP): A Novel Target for Cancer Therapy
Current Cancer Drug Targets Role of Netrin-1 Beyond the Brain: From Biomarker of Tissue Injury to Therapy for Inflammatory Diseases
Recent Patents on Biomarkers Recombinant Allergens for Diagnosis and Immunotherapy of Allergic Disorders, with Emphasis on Cockroach Allergy
Current Protein & Peptide Science Role of Nitric Oxide in Motor Control: Implications for Parkinsons Disease Pathophysiology and Treatment
Current Pharmaceutical Design Autophagy Modulators and Neuroinflammation
Current Medicinal Chemistry Oyster Mushroom Laccase Inhibits Hepatitis C Virus Entry into Peripheral Blood Cells and Hepatoma Cells
Protein & Peptide Letters Nitric Oxide-Releasing Nonsteroidal Anti-inflammatory Drugs Novel Gastrointestinal-Sparing Drugs
Mini-Reviews in Medicinal Chemistry Antioxidative Activities of Medicinal Plants from TCM
Mini-Reviews in Medicinal Chemistry Sex Differences and Emerging New Risk Factors for Atherosclerosis and Its Thrombotic Complications
Current Pharmaceutical Design Evidence for Complex Binding Profiles and Species Differences at the Translocator Protein (TSPO) (18 kDa)
Current Molecular Medicine Diclofenac 1,3,4-Oxadiazole Derivatives; Biology-Oriented Drug Synthesis (BIODS) in Search of Better Non-Steroidal, Non-Acid Antiinflammatory Agents
Medicinal Chemistry Construction of an Anti-IL-1β scfv and TNFRI Fusion Protein and Its Therapeutic Effect on RA Mice Model
Current Pharmaceutical Biotechnology Preferential Interaction of β-Globulin from Sesame Seeds (Sesamum indicum L.) with Cosolvents Is Accompanied by the Protein Structural Reorganization
Protein & Peptide Letters Harnessing Immunologic Tools to Treat Gynecologic Disorders
Current Women`s Health Reviews Healing Effects of Curcumin Nanoparticles in Deep Tissue Injury Mouse Model
Current Drug Delivery Stroke: Molecular Mechanisms and Potential Targets for Treatment
Current Molecular Medicine Hyperglycemia to Nephropathy via Transforming Growth Factor Beta
Current Diabetes Reviews Gastric Mucosal Protection And Central Nervous System
Current Pharmaceutical Design Current Treatment of Psoriasis with Biologics
Current Drug Discovery Technologies